Search

Your search keyword '"Kwak, Larry W."' showing total 988 results
Start Over "Kwak, Larry W."
988 results on '"Kwak, Larry W."'

1. Personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma: a non-randomized phase 1 trial

Author

Szymura, Szymon J., Wang, Lin, Zhang, Tiantian, Cha, Soung-chul, Song, Joo, Dong, Zhenyuan, Anderson, Aaron, Oh, Elizabeth, Lee, Vincent, Wang, Zhe, Parshottam, Sapna, Rao, Sheetal, Olsem, Jasper B., Crumpton, Brandon N., Lee, Hans C., Manasanch, Elisabet E., Neelapu, Sattva, Kwak, Larry W., and Thomas, Sheeba K.

Published
2024
Full Text
View/download PDF

5. Brentuximab vedotin plus nivolumab after autologous haematopoietic stem-cell transplantation for adult patients with high-risk classic Hodgkin lymphoma: a multicentre, phase 2 trial

Author

Herrera, Alex F, Chen, Lu, Nieto, Yago, Holmberg, Leona, Johnston, Patrick, Mei, Matthew, Popplewell, Leslie, Armenian, Saro, Cao, Thai, Farol, Leonardo, Sahebi, Firoozeh, Spielberger, Ricardo, Chen, Robert, Nademanee, Auayporn, Puverel, Sandrine, Nwangwu, Mary, Lee, Peter, Song, Joo, Skarbnik, Alan, Kennedy, Neena, Peters, Lacolle, Rosen, Steven T, Kwak, Larry W, Forman, Stephen J, and Feldman, Tatyana

Published
2023
Full Text
View/download PDF

6. PMB-CT01 (BAFFR-CAR T cell) therapy to examine preliminary safety and clinical responses in patients with B-cell malignancies who are ineligible for or failed CD19-directed therapy, including CD19-negative disease.

Author

Budde, Lihua Elizabeth, primary, Del Real, Marissa, additional, Baird, John H., additional, Chen, Lu, additional, Song, Joo Y, additional, Wang, Xiuli, additional, Kambhampati, Swetha, additional, Macias, Alan, additional, Kim, Teresa, additional, Dulan, Sylvia, additional, Barva, Baishakhi, additional, Guan, Min, additional, Espinosa, Ruby, additional, Puverel, Sandrine, additional, Tiemann, Katrin, additional, Cheng, Hazel (Ting-Ying), additional, Forman, Stephen J., additional, Kwak, Larry W., additional, and Aldoss, Ibrahim, additional

Published
2024
Full Text
View/download PDF

10. A randomized phase 2 trial of idiotype vaccination and adoptive autologous T-cell transfer in patients with multiple myeloma

Author

Qazilbash, Muzaffar H., Saini, Neeraj Y., Cha, Soung-chul, Wang, Zhe, Stadtmauer, Edward A., Baladandayuthapani, Veerabhadran, Lin, Heather, Tross, Beryl, Honhar, Medhavi, Rao, Sheetal S., Kim, Kunhwa, Popescu, Michael, Szymura, Szymon, Zhang, Tiantian, Anderson, Aaron, Bashir, Qaiser, Shpall, Elizabeth J., Orlowski, Robert Z., Levine, Bruce L., Kerr, Naseem, Garfall, Alfred, Cohen, Adam, Vogl, Dan T., Dengel, Karen, June, Carl H., Champlin, Richard, and Kwak, Larry W.

Published
2022
Full Text
View/download PDF

11. Efficacy and Safety of CT-P10 Versus Rituximab in Untreated Low-Tumor-Burden Follicular Lymphoma: Final Results of a Randomized Phase III Study

Author

Kwak, Larry W., Sancho, Juan-Manuel, Cho, Seok-Goo, Nakazawa, Hideyuki, Suzumiya, Junji, Tumyan, Gayane, Kim, Jin Seok, Menne, Tobias, Mariz, José, Ilyin, Nikolai, Jurczak, Wojciech, Lopez Martinez, Aurelio, Samoilova, Olga, Zhavrid, Edvard, Yañez Ruiz, Eduardo, Trneny, Marek, Popplewell, Leslie, Ogura, Michinori, Kim, Won-Seog, Lee, Sang Joon, Kim, Sung Hyun, Ahn, Keum Young, and Buske, Christian

Published
2022
Full Text
View/download PDF

12. Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma

Author

Godfrey, James K., primary, Gao, Lei, additional, Shouse, Geoffrey, additional, Song, Joo Y., additional, Pak, Stacy, additional, Lee, Brian, additional, Chen, Bihong T., additional, Kallam, Avyakta, additional, Baird, John H., additional, Marcucci, Guido, additional, Ghoda, Lucy Y., additional, Vauleon, Stephanie, additional, Danilov, Alexey V, additional, Herrera, Alex F., additional, Kwak, Larry W, additional, and Budde, Lihua E, additional

Published
2024
Full Text
View/download PDF

15. CCL3 and CCL4 are biomarkers for B cell receptor pathway activation and prognostic serum markers in diffuse large B cell lymphoma

Author

Takahashi, Koichi, Sivina, Mariela, Hoellenriegel, Julia, Oki, Yasuhiro, Hagemeister, Fredrick B, Fayad, Luis, Romaguera, Jorge E, Fowler, Nathan, Fanale, Michelle A, Kwak, Larry W, Samaniego, Felipe, Neelapu, Sattva, Xiao, Lianchun, Huang, Xuelin, Kantarjian, Hagop, Keating, Michael J, Wierda, William, Fu, Kai, Chan, Wing C, Vose, Julie M, O'Brien, Susan, Davis, Richard E, and Burger, Jan A

Subjects
Biomedical and Clinical Sciences, Cardiovascular Medicine and Haematology, Oncology and Carcinogenesis, Cancer, Rare Diseases, Lymphoma, Hematology, Clinical Research, Aetiology, 2.1 Biological and endogenous factors, Adenine, Antineoplastic Agents, B-Cell Activation Factor Receptor, Biomarkers, Tumor, Cell Line, Tumor, Chemokine CCL3, Chemokine CCL4, Enzyme-Linked Immunosorbent Assay, Epidemiologic Methods, Humans, Lymphoma, Large B-Cell, Diffuse, Piperidines, Prognosis, Pyrazoles, Pyrimidines, Signal Transduction, chemokines, diffuse large B-cell lymphoma, lymphoma, Cardiorespiratory Medicine and Haematology, Immunology, Cardiovascular medicine and haematology
Abstract

B cell receptor (BCR) signalling is an important pathway in diffuse large B cell lymphoma (DLBCL). In response to BCR triggering, normal and malignant B cells secrete the chemokines CCL3 and CCL4 to attract accessory cells to the tissue microenvironment. We measured CCL3 and CCL4 serum concentrations in 102 patients with newly diagnosed DLBCL by enzyme-linked immunosorbent assay, investigated their prognostic impact and validated our findings in an independent cohort of 51 patient samples. We also tested CCL3 and CCL4 secretion by DLBCL cells, and the influence of BTK inhibitors on the secretion of these chemokines. High CCL3 (≥40 pg/ml) serum concentrations correlated with higher international prognostic index, lactate dehydrogenase and β2 microglobulin, as did CCL4 (≥180 pg/ml) with advanced Ann Arbor stages. High CCL3 levels correlated with significantly shorter progression-free and overall survival. The in vitro studies demonstrated that activated B cell-like, but not germinal centre B cell-like DLBCL cells, secrete high levels of CCL3 and CCL4 after BCR triggering, which was exquisitely sensitive to BCR pathway inhibition. These findings support CCL3 and CCL4 protein concentrations as biomarkers for BCR pathway activation and prognosis in DLBCL.

Published
2015

18. Efficacy, pharmacokinetics, and safety of the biosimilar CT-P10 in comparison with rituximab in patients with previously untreated low-tumour-burden follicular lymphoma: a randomised, double-blind, parallel-group, phase 3 trial

Author

Ogura, Michinori, Sancho, Juan Manuel, Cho, Seok-Goo, Nakazawa, Hideyuki, Suzumiya, Junji, Tumyan, Gayane, Kim, Jin Seok, Lennard, Anne, Mariz, José, Ilyin, Nikolai, Jurczak, Wojciech, Lopez Martinez, Aurelio, Samoilova, Olga, Zhavrid, Edvard, Yañez Ruiz, Eduardo, Trneny, Marek, Popplewell, Leslie, Coiffier, Bertrand, Buske, Christian, Kim, Won-Seog, Lee, Sang Joon, Lee, Sung Young, Bae, Yun Ju, and Kwak, Larry W

Published
2018
Full Text
View/download PDF

19. Results from a phase I trial of pembrolizumab plus vorinostat in relapsed/refractory B-cell non-Hodgkin lymphoma

Author

Godfrey, James, primary, Mei, Matthew, additional, Chen, Lu, additional, Song, Joo Y., additional, Bedell, Victoria, additional, Budde, Elizabeth, additional, Armenian, Saro, additional, Puverel, Sandrine, additional, Nikolaenko, Liana, additional, Chen, Robert, additional, Daniels, Shari, additional, Kennedy, Neena, additional, Peters, Lacolle, additional, Rosen, Steven T., additional, Forman, Stephen J., additional, Popplewell, Leslie L., additional, Kwak, Larry W., additional, and Herrera, Alex F., additional

Published
2023
Full Text
View/download PDF

20. Outcomes after Allogeneic Stem Cell Transplantation in Patients with Double-Hit and Double-Expressor Lymphoma

Author

Herrera, Alex F., Rodig, Scott J., Song, Joo Y., Kim, Young, Griffin, Gabriel K., Yang, Dongyun, Nikolaenko, Liana, Mei, Matthew, Bedell, Victoria, Dal Cin, Paola, Pak, Christine, Alyea, Edwin P., Budde, Lihua E., Chen, Robert, Chen, Yi-Bin, Chan, Wing C., Cutler, Corey S., Ho, Vincent T., Koreth, John, Krishnan, Amrita, Murata-Collins, Joyce L., Nikiforow, Sarah, Palmer, Joycelynne, Pihan, German A., Pillai, Raju, Popplewell, Leslie, Rosen, Steven T., Siddiqi, Tanya, Sohani, Aliyah R., Zain, Jasmine, Kwak, Larry W., Weisenburger, Dennis D., Weinstock, David M., Soiffer, Robert J., Antin, Joseph H., Forman, Stephen J., Nademanee, Auayporn P., and Armand, Philippe

Published
2018
Full Text
View/download PDF

21. Data from The Cerebroventricular Environment Modifies CAR T Cells for Potent Activity against Both Central Nervous System and Systemic Lymphoma

Author

Wang, Xiuli, primary, Huynh, Christian, primary, Urak, Ryan, primary, Weng, Lihong, primary, Walter, Miriam, primary, Lim, Laura, primary, Vyas, Vibhuti, primary, Chang, Wen-Chung, primary, Aguilar, Brenda, primary, Brito, Alfonso, primary, Sarkissian, Aniee, primary, Bandara, N. Achini, primary, Yang, Lu, primary, Wang, Jinhui, primary, Wu, Xiwei, primary, Zhang, Jianying, primary, Priceman, Saul J., primary, Qin, Hong, primary, Kwak, Larry W., primary, Budde, Lihua E., primary, Thomas, Sandra H., primary, Clark, Mary C., primary, Popplewell, Leslie, primary, Siddiqi, Tanya, primary, Brown, Christine E., primary, and Forman, Stephen J., primary

Published
2023
Full Text
View/download PDF

22. Supplementary Figures from The Cerebroventricular Environment Modifies CAR T Cells for Potent Activity against Both Central Nervous System and Systemic Lymphoma

Author

Wang, Xiuli, primary, Huynh, Christian, primary, Urak, Ryan, primary, Weng, Lihong, primary, Walter, Miriam, primary, Lim, Laura, primary, Vyas, Vibhuti, primary, Chang, Wen-Chung, primary, Aguilar, Brenda, primary, Brito, Alfonso, primary, Sarkissian, Aniee, primary, Bandara, N. Achini, primary, Yang, Lu, primary, Wang, Jinhui, primary, Wu, Xiwei, primary, Zhang, Jianying, primary, Priceman, Saul J., primary, Qin, Hong, primary, Kwak, Larry W., primary, Budde, Lihua E., primary, Thomas, Sandra H., primary, Clark, Mary C., primary, Popplewell, Leslie, primary, Siddiqi, Tanya, primary, Brown, Christine E., primary, and Forman, Stephen J., primary

Published
2023
Full Text
View/download PDF

23. Supplementary Table 1 from In Vitro and In Vivo Therapeutic Efficacy of Carfilzomib in Mantle Cell Lymphoma: Targeting the Immunoproteasome

Author

Zhang, Liang, primary, Pham, Lan V., primary, Newberry, Kate J., primary, Ou, Zhishuo, primary, Liang, Rong, primary, Qian, Jianfei, primary, Sun, Luhong, primary, Blonska, Marzenna, primary, You, Yun, primary, Yang, Jing, primary, Lin, Xin, primary, Rollo, Alex, primary, Tamayo, Archito T., primary, Lee, John, primary, Ford, Richard J., primary, Zhao, Xiurong, primary, Kwak, Larry W., primary, Yi, Qing, primary, and Wang, Michael, primary

Published
2023
Full Text
View/download PDF

25. Supplementary Figure 1 from In Vitro and In Vivo Therapeutic Efficacy of Carfilzomib in Mantle Cell Lymphoma: Targeting the Immunoproteasome

Author

Zhang, Liang, primary, Pham, Lan V., primary, Newberry, Kate J., primary, Ou, Zhishuo, primary, Liang, Rong, primary, Qian, Jianfei, primary, Sun, Luhong, primary, Blonska, Marzenna, primary, You, Yun, primary, Yang, Jing, primary, Lin, Xin, primary, Rollo, Alex, primary, Tamayo, Archito T., primary, Lee, John, primary, Ford, Richard J., primary, Zhao, Xiurong, primary, Kwak, Larry W., primary, Yi, Qing, primary, and Wang, Michael, primary

Published
2023
Full Text
View/download PDF

26. Data from In Vitro and In Vivo Therapeutic Efficacy of Carfilzomib in Mantle Cell Lymphoma: Targeting the Immunoproteasome

Author

Zhang, Liang, primary, Pham, Lan V., primary, Newberry, Kate J., primary, Ou, Zhishuo, primary, Liang, Rong, primary, Qian, Jianfei, primary, Sun, Luhong, primary, Blonska, Marzenna, primary, You, Yun, primary, Yang, Jing, primary, Lin, Xin, primary, Rollo, Alex, primary, Tamayo, Archito T., primary, Lee, John, primary, Ford, Richard J., primary, Zhao, Xiurong, primary, Kwak, Larry W., primary, Yi, Qing, primary, and Wang, Michael, primary

Published
2023
Full Text
View/download PDF

29. Efficacy, pharmacokinetics, and safety of the biosimilar CT-P10 compared with rituximab in patients with previously untreated advanced-stage follicular lymphoma: a randomised, double-blind, parallel-group, non-inferiority phase 3 trial

Author

Kim, Won Seog, Buske, Christian, Ogura, Michinori, Jurczak, Wojciech, Sancho, Juan-Manuel, Zhavrid, Edvard, Kim, Jin Seok, Hernández-Rivas, José-Ángel, Prokharau, Aliaksandr, Vasilica, Mariana, Nagarkar, Rajinish, Osmanov, Dzhelil, Kwak, Larry W, Lee, Sang Joon, Lee, Sung Young, Bae, Yun Ju, and Coiffier, Bertrand

Published
2017
Full Text
View/download PDF

32. Supplementary Table 3 from Effect of Long-term Storage in TRIzol on Microarray-Based Gene Expression Profiling

Author

Ma, Wencai, primary, Wang, Michael, primary, Wang, Zhi-Qiang, primary, Sun, Luhong, primary, Graber, David, primary, Matthews, Jairo, primary, Champlin, Richard, primary, Yi, Qing, primary, Orlowski, Robert Z., primary, Kwak, Larry W., primary, Weber, Donna M., primary, Thomas, Sheeba K., primary, Shah, Jatin, primary, Kornblau, Steven, primary, and Davis, Richard E., primary

Published
2023
Full Text
View/download PDF

33. Supplementary Figure 1 from Inhibition of MDR1 Overcomes Resistance to Brentuximab Vedotin in Hodgkin Lymphoma

Author

Chen, Robert, primary, Herrera, Alex F., primary, Hou, Jessie, primary, Chen, Lu, primary, Wu, Jun, primary, Guo, Yuming, primary, Synold, Timothy W., primary, Ngo, Vu N., primary, Puverel, Sandrine, primary, Mei, Matthew, primary, Popplewell, Leslie, primary, Yi, Shuhua, primary, Song, Joo Y., primary, Tao, Shu, primary, Wu, Xiwei, primary, Chan, Wing C., primary, Forman, Stephen J., primary, Kwak, Larry W., primary, Rosen, Steven T., primary, and Newman, Edward M., primary

Published
2023
Full Text
View/download PDF

34. Supplementary Figure 2 from Inhibition of MDR1 Overcomes Resistance to Brentuximab Vedotin in Hodgkin Lymphoma

Author

Chen, Robert, primary, Herrera, Alex F., primary, Hou, Jessie, primary, Chen, Lu, primary, Wu, Jun, primary, Guo, Yuming, primary, Synold, Timothy W., primary, Ngo, Vu N., primary, Puverel, Sandrine, primary, Mei, Matthew, primary, Popplewell, Leslie, primary, Yi, Shuhua, primary, Song, Joo Y., primary, Tao, Shu, primary, Wu, Xiwei, primary, Chan, Wing C., primary, Forman, Stephen J., primary, Kwak, Larry W., primary, Rosen, Steven T., primary, and Newman, Edward M., primary

Published
2023
Full Text
View/download PDF

35. Data from Inhibition of MDR1 Overcomes Resistance to Brentuximab Vedotin in Hodgkin Lymphoma

Author

Chen, Robert, primary, Herrera, Alex F., primary, Hou, Jessie, primary, Chen, Lu, primary, Wu, Jun, primary, Guo, Yuming, primary, Synold, Timothy W., primary, Ngo, Vu N., primary, Puverel, Sandrine, primary, Mei, Matthew, primary, Popplewell, Leslie, primary, Yi, Shuhua, primary, Song, Joo Y., primary, Tao, Shu, primary, Wu, Xiwei, primary, Chan, Wing C., primary, Forman, Stephen J., primary, Kwak, Larry W., primary, Rosen, Steven T., primary, and Newman, Edward M., primary

Published
2023
Full Text
View/download PDF

36. Supplementary Figure 3 from Inhibition of MDR1 Overcomes Resistance to Brentuximab Vedotin in Hodgkin Lymphoma

Author

Chen, Robert, primary, Herrera, Alex F., primary, Hou, Jessie, primary, Chen, Lu, primary, Wu, Jun, primary, Guo, Yuming, primary, Synold, Timothy W., primary, Ngo, Vu N., primary, Puverel, Sandrine, primary, Mei, Matthew, primary, Popplewell, Leslie, primary, Yi, Shuhua, primary, Song, Joo Y., primary, Tao, Shu, primary, Wu, Xiwei, primary, Chan, Wing C., primary, Forman, Stephen J., primary, Kwak, Larry W., primary, Rosen, Steven T., primary, and Newman, Edward M., primary

Published
2023
Full Text
View/download PDF

37. Supplementary Table 2 from Effect of Long-term Storage in TRIzol on Microarray-Based Gene Expression Profiling

Author

Ma, Wencai, primary, Wang, Michael, primary, Wang, Zhi-Qiang, primary, Sun, Luhong, primary, Graber, David, primary, Matthews, Jairo, primary, Champlin, Richard, primary, Yi, Qing, primary, Orlowski, Robert Z., primary, Kwak, Larry W., primary, Weber, Donna M., primary, Thomas, Sheeba K., primary, Shah, Jatin, primary, Kornblau, Steven, primary, and Davis, Richard E., primary

Published
2023
Full Text
View/download PDF

38. Supplementary Materials and Methods from Inhibition of MDR1 Overcomes Resistance to Brentuximab Vedotin in Hodgkin Lymphoma

Author

Chen, Robert, primary, Herrera, Alex F., primary, Hou, Jessie, primary, Chen, Lu, primary, Wu, Jun, primary, Guo, Yuming, primary, Synold, Timothy W., primary, Ngo, Vu N., primary, Puverel, Sandrine, primary, Mei, Matthew, primary, Popplewell, Leslie, primary, Yi, Shuhua, primary, Song, Joo Y., primary, Tao, Shu, primary, Wu, Xiwei, primary, Chan, Wing C., primary, Forman, Stephen J., primary, Kwak, Larry W., primary, Rosen, Steven T., primary, and Newman, Edward M., primary

Published
2023
Full Text
View/download PDF

39. All Supplementary Data from Novel BAFF-Receptor Antibody to Natively Folded Recombinant Protein Eliminates Drug-Resistant Human B-cell Malignancies In Vivo

Author

Qin, Hong, primary, Wei, Guowei, primary, Sakamaki, Ippei, primary, Dong, Zhenyuan, primary, Cheng, Wesley A., primary, Smith, D. Lynne, primary, Wen, Feng, primary, Sun, Han, primary, Kim, Kunhwa, primary, Cha, Soungchul, primary, Bover, Laura, primary, Neelapu, Sattva S., primary, and Kwak, Larry W., primary

Published
2023
Full Text
View/download PDF

40. Supplementary Data from Double-hit Signature with TP53 Abnormalities Predicts Poor Survival in Patients with Germinal Center Type Diffuse Large B-cell Lymphoma Treated with R-CHOP

Author

Song, Joo Y., primary, Perry, Anamarija M., primary, Herrera, Alex F., primary, Chen, Lu, primary, Skrabek, Pamela, primary, Nasr, Michel R., primary, Ottesen, Rebecca A., primary, Nikowitz, Janet, primary, Bedell, Victoria, primary, Murata-Collins, Joyce, primary, Li, Yuping, primary, McCarthy, Christine, primary, Pillai, Raju, primary, Wang, Jinhui, primary, Wu, Xiwei, primary, Zain, Jasmine, primary, Popplewell, Leslie, primary, Kwak, Larry W., primary, Nademanee, Auayporn P., primary, Niland, Joyce C., primary, Scott, David W., primary, Gong, Qiang, primary, Chan, Wing C., primary, and Weisenburger, Dennis D., primary

Published
2023
Full Text
View/download PDF

41. Supplementary Figure legends from Inhibition of MDR1 Overcomes Resistance to Brentuximab Vedotin in Hodgkin Lymphoma

Author

Chen, Robert, primary, Herrera, Alex F., primary, Hou, Jessie, primary, Chen, Lu, primary, Wu, Jun, primary, Guo, Yuming, primary, Synold, Timothy W., primary, Ngo, Vu N., primary, Puverel, Sandrine, primary, Mei, Matthew, primary, Popplewell, Leslie, primary, Yi, Shuhua, primary, Song, Joo Y., primary, Tao, Shu, primary, Wu, Xiwei, primary, Chan, Wing C., primary, Forman, Stephen J., primary, Kwak, Larry W., primary, Rosen, Steven T., primary, and Newman, Edward M., primary

Published
2023
Full Text
View/download PDF

42. Supplementary Table 1 from Effect of Long-term Storage in TRIzol on Microarray-Based Gene Expression Profiling

Author

Ma, Wencai, primary, Wang, Michael, primary, Wang, Zhi-Qiang, primary, Sun, Luhong, primary, Graber, David, primary, Matthews, Jairo, primary, Champlin, Richard, primary, Yi, Qing, primary, Orlowski, Robert Z., primary, Kwak, Larry W., primary, Weber, Donna M., primary, Thomas, Sheeba K., primary, Shah, Jatin, primary, Kornblau, Steven, primary, and Davis, Richard E., primary

Published
2023
Full Text
View/download PDF

43. Supplementary Table 1 from Inhibition of MDR1 Overcomes Resistance to Brentuximab Vedotin in Hodgkin Lymphoma

Author

Chen, Robert, primary, Herrera, Alex F., primary, Hou, Jessie, primary, Chen, Lu, primary, Wu, Jun, primary, Guo, Yuming, primary, Synold, Timothy W., primary, Ngo, Vu N., primary, Puverel, Sandrine, primary, Mei, Matthew, primary, Popplewell, Leslie, primary, Yi, Shuhua, primary, Song, Joo Y., primary, Tao, Shu, primary, Wu, Xiwei, primary, Chan, Wing C., primary, Forman, Stephen J., primary, Kwak, Larry W., primary, Rosen, Steven T., primary, and Newman, Edward M., primary

Published
2023
Full Text
View/download PDF

44. Data from p38 MAPK in Myeloma Cells Regulates Osteoclast and Osteoblast Activity and Induces Bone Destruction

Author

He, Jin, primary, Liu, Zhiqiang, primary, Zheng, Yuhuan, primary, Qian, Jianfei, primary, Li, Haiyan, primary, Lu, Yong, primary, Xu, Jingda, primary, Hong, Bangxing, primary, Zhang, Mingjun, primary, Lin, Pei, primary, Cai, Zhen, primary, Orlowski, Robert Z., primary, Kwak, Larry W., primary, Yi, Qing, primary, and Yang, Jing, primary

Published
2023
Full Text
View/download PDF

45. Supplementary Figure 1 from p38 MAPK in Myeloma Cells Regulates Osteoclast and Osteoblast Activity and Induces Bone Destruction

Author

He, Jin, primary, Liu, Zhiqiang, primary, Zheng, Yuhuan, primary, Qian, Jianfei, primary, Li, Haiyan, primary, Lu, Yong, primary, Xu, Jingda, primary, Hong, Bangxing, primary, Zhang, Mingjun, primary, Lin, Pei, primary, Cai, Zhen, primary, Orlowski, Robert Z., primary, Kwak, Larry W., primary, Yi, Qing, primary, and Yang, Jing, primary

Published
2023
Full Text
View/download PDF

46. Supplementary Methods from p38 MAPK in Myeloma Cells Regulates Osteoclast and Osteoblast Activity and Induces Bone Destruction

Author

He, Jin, primary, Liu, Zhiqiang, primary, Zheng, Yuhuan, primary, Qian, Jianfei, primary, Li, Haiyan, primary, Lu, Yong, primary, Xu, Jingda, primary, Hong, Bangxing, primary, Zhang, Mingjun, primary, Lin, Pei, primary, Cai, Zhen, primary, Orlowski, Robert Z., primary, Kwak, Larry W., primary, Yi, Qing, primary, and Yang, Jing, primary

Published
2023
Full Text
View/download PDF

47. Real-World Outcomes of CD19 CAR T Cell Therapy in Adult Patients with Relapsed Refractory Transformed Diffuse Large B-Cell Lymphoma

Author

Kambhampati, Swetha, primary, Popplewell, Leslie, additional, Wang, Yan, additional, Mei, Matthew, additional, Nikolaenko, Liana, additional, Shouse, Geoffrey, additional, Herrera, Alex F., additional, Zain, Jasmine, additional, Siddiqi, Tanya, additional, Godfrey, James, additional, Baird, Dr. John H, additional, Rosen, Steven, additional, Danilov, Alexey V., additional, Cai, Ji-Lian, additional, Spielberger, Ricardo, additional, Palmer, Joycelynne, additional, Brown, Annette, additional, Kwak, Larry W., additional, Smith, Eileen, additional, Forman, Stephen J., additional, and Budde, L. Elizabeth E., additional

Published
2023
Full Text
View/download PDF

49. Pegylated Liposomal Doxorubicin Replacing Conventional Doxorubicin in Standard R-CHOP Chemotherapy for Elderly Patients With Diffuse Large B-Cell Lymphoma: An Open Label, Single Arm, Phase II Trial

Author

Oki, Yasuhiro, Ewer, Michael S., Lenihan, Daniel J., Fisch, Michael J., Hagemeister, Fredrick B., Fanale, Michelle, Romaguera, Jorge, Pro, Barbara, Fowler, Nathan, Younes, Anas, Astrow, Alan B., Huang, Xuelin, Kwak, Larry W., Samaniego, Felipe, McLaughlin, Peter, Neelapu, Sattva S., Wang, Michael, Fayad, Luis E., Durand, Jean-Bernard, and Alma Rodriguez, M.

Published
2015
Full Text
View/download PDF

50. Polatuzumab Vedotin Combined with R-ICE (PolaR-ICE) As Second-Line Therapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Author

Herrera, Alex F., primary, Chen, Lu, additional, Crombie, Jennifer L., additional, Cohen, Jonathon B., additional, Advani, Ranjana H., additional, LaCasce, Ann S., additional, Popplewell, Leslie L., additional, Puverel, Sandrine, additional, Peters, Lacolle, additional, Daniels, Shari, additional, Godfrey, James, additional, Shouse, Geoffrey, additional, Mei, Matthew, additional, Kambhampati, Swetha, additional, Budde, L. Elizabeth, additional, Nikolaenko, Liana, additional, Rosen, Steven T., additional, Kwak, Larry W., additional, Forman, Stephen J, additional, and Matasar, Matthew J., additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results